Interpreting Anti-HLA Antibody Testing Data

A Practical Guide for Physicians

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

ABSTRACT: The development of sensitive methods for alloantibody detection has been a significant advance in clinical transplantation. However, the complexity of the data from solid phase and crossmatch assays has led to potential confusion about how to use the results for clinical decision making. The goal of this review is to provide a practical guide for transplant physicians for the interpretation of antibody data to supplement consultation with local tissue typing experts. Sources of variability in both the solid phase and crossmatch assay are discussed as are recent data regarding C1q binding antibodies and IgG subclass testing. Although definitive approaches to alloantibody testing are not possible with our current knowledge, we outline a pragmatic approach that we hope will enhance clinical management in this area.

Original languageEnglish (US)
JournalTransplantation
DOIs
StateAccepted/In press - May 2 2016

Fingerprint

Isoantibodies
Anti-Idiotypic Antibodies
Physicians
Histocompatibility Testing
Antibodies
Referral and Consultation
Immunoglobulin G
Transplantation
Transplants
Clinical Decision-Making

ASJC Scopus subject areas

  • Transplantation

Cite this

Interpreting Anti-HLA Antibody Testing Data : A Practical Guide for Physicians. / Schinstock, Carrie; Gandhi, Manish J.; Stegall, Mark D.

In: Transplantation, 02.05.2016.

Research output: Contribution to journalArticle

@article{8896eb3df0ea4106bcf5223abded0a4a,
title = "Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians",
abstract = "ABSTRACT: The development of sensitive methods for alloantibody detection has been a significant advance in clinical transplantation. However, the complexity of the data from solid phase and crossmatch assays has led to potential confusion about how to use the results for clinical decision making. The goal of this review is to provide a practical guide for transplant physicians for the interpretation of antibody data to supplement consultation with local tissue typing experts. Sources of variability in both the solid phase and crossmatch assay are discussed as are recent data regarding C1q binding antibodies and IgG subclass testing. Although definitive approaches to alloantibody testing are not possible with our current knowledge, we outline a pragmatic approach that we hope will enhance clinical management in this area.",
author = "Carrie Schinstock and Gandhi, {Manish J.} and Stegall, {Mark D}",
year = "2016",
month = "5",
day = "2",
doi = "10.1097/TP.0000000000001203",
language = "English (US)",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Interpreting Anti-HLA Antibody Testing Data

T2 - A Practical Guide for Physicians

AU - Schinstock, Carrie

AU - Gandhi, Manish J.

AU - Stegall, Mark D

PY - 2016/5/2

Y1 - 2016/5/2

N2 - ABSTRACT: The development of sensitive methods for alloantibody detection has been a significant advance in clinical transplantation. However, the complexity of the data from solid phase and crossmatch assays has led to potential confusion about how to use the results for clinical decision making. The goal of this review is to provide a practical guide for transplant physicians for the interpretation of antibody data to supplement consultation with local tissue typing experts. Sources of variability in both the solid phase and crossmatch assay are discussed as are recent data regarding C1q binding antibodies and IgG subclass testing. Although definitive approaches to alloantibody testing are not possible with our current knowledge, we outline a pragmatic approach that we hope will enhance clinical management in this area.

AB - ABSTRACT: The development of sensitive methods for alloantibody detection has been a significant advance in clinical transplantation. However, the complexity of the data from solid phase and crossmatch assays has led to potential confusion about how to use the results for clinical decision making. The goal of this review is to provide a practical guide for transplant physicians for the interpretation of antibody data to supplement consultation with local tissue typing experts. Sources of variability in both the solid phase and crossmatch assay are discussed as are recent data regarding C1q binding antibodies and IgG subclass testing. Although definitive approaches to alloantibody testing are not possible with our current knowledge, we outline a pragmatic approach that we hope will enhance clinical management in this area.

UR - http://www.scopus.com/inward/record.url?scp=84965028209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84965028209&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000001203

DO - 10.1097/TP.0000000000001203

M3 - Article

JO - Transplantation

JF - Transplantation

SN - 0041-1337

ER -